Lexicon Genetics Incorporated, a biopharmaceutical company, engages in the discovery of functions and pharmaceutical utility of genes, and using those gene function discoveries in the discovery and development of pharmaceutical products for the treatment of human disease. The company discovers the physiological and behavioral functions of genes to identify potential points of therapeutic intervention or drug targets using the gene knockout technology. It has advanced knockout-validated targets in drug discovery programs in various therapeutic areas, including diabetes and obesity, cardiovascular disease, psychiatric and neurological disorders, cancer, immune system disorders, and...